(PRFZ) FTSE RAFI US 1500 Small-Mid - Overview
Etf: Stocks, Small-Mid, Book, Cash-Flow, Sales, Dividends
Dividends
| Dividend Yield | 0.86% |
| Yield on Cost 5y | 1.16% |
| Yield CAGR 5y | -32.13% |
| Payout Consistency | 92.8% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.9% |
| Relative Tail Risk | -4.04% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.50 |
| Alpha | -1.96 |
| Character TTM | |
|---|---|
| Beta | 1.014 |
| Beta Downside | 0.989 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.53% |
| CAGR/Max DD | 0.52 |
Description: PRFZ FTSE RAFI US 1500 Small-Mid January 13, 2026
The Invesco FTSE RAFI US 1500 Small-Mid ETF (NASDAQ: PRFZ) commits at least 90 % of its net assets to the FTSE RAFI US 1500 Small-Mid Index, a fundamentally weighted basket of roughly 1,500 U.S. equities. The index allocates capital based on four size-related fundamentals-book value, cash flow, sales, and dividends-rather than market capitalization, aiming to capture value-tilted exposure across the small- and mid-cap spectrum.
Key fund metrics (as of Q4 2025) include an expense ratio of 0.35 % and assets under management of about $1.3 billion. The portfolio turnover is moderate (~30 % annually), reflecting the relative stability of the underlying fundamentals. The dividend yield hovers around 1.1 %, modest for a value-focused small-cap vehicle.
From a macro-economic perspective, PRFZ’s performance is sensitive to U.S. GDP growth and monetary policy. Small- and mid-cap firms tend to outperform when the economy is expanding and interest rates are stable, as they rely more on internal cash generation than cheap financing. Conversely, tightening cycles can compress valuations, especially for cash-flow-heavy constituents.
Sector concentration leans toward technology (≈ 20 % of assets) and consumer discretionary (≈ 15 %), both of which are driven by discretionary spending trends and innovation cycles-areas where fundamental strength can diverge sharply from price momentum.
For a deeper quantitative breakdown of PRFZ’s factor exposures and risk profile, you might explore ValueRay’s analytics platform.
What is the price of PRFZ shares?
Over the past week, the price has changed by +2.26%, over one month by +2.67%, over three months by +10.30% and over the past year by +13.61%.
Is PRFZ a buy, sell or hold?
What are the forecasts/targets for the PRFZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 51.6 | 5.6% |
PRFZ Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.74b USD (2.74b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.74b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.74b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.65% (E(2.74b)/V(2.74b) * Re(9.65%) + (debt-free company))
Discount Rate = 9.65% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)